(Nasdaq: CTXR) - Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally
Crypto.com coin tumbles 17% after the digital currencies exchange cuts down rewards to cardholders Crypto.com's CRO coin dropped Monday after ...
The successful completion of the Business Combination continues SoundHounds momentum over recent months with respect to key customers and expansion ...
GTY Technology Holdings Inc. (NASDAQ: GTYH) stated it entered into a definitive agreement to be acquired by a private investment ...
Amazon shares fall on bleak forecast and slowest growth since dot-com bust
PENNSAUKEN, N.J. , April 27, 2022 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and ...
AMSTERDAM, April 28, 2022 /PRNewswire/ --VEON Ltd. (VEON) announces a trading update for the first quarter ended 31 March 2022, ...
Atlanta, GA , April 28, 2022 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity ...
FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (NASDAQ:STAB) (the "Company"), a biopharmaceutical company creating next-generation immune ...
